24 Aug 2026 Punjab Khabarnama Bureau : India is emerging as an important hub for cancer research and healthcare innovation, with researchers and laboratories developing new approaches to diagnosis, treatment and personalised cancer care.
From indigenous CAR-T cell therapy to artificial intelligence, genomics and advanced surgical technologies, these innovations are aimed at making cancer treatment more precise and potentially more accessible.
Indigenous CAR-T Therapy
One of India’s major achievements in cancer innovation is NexCAR19, an indigenous CAR-T cell therapy developed through collaboration involving IIT Bombay, Tata Memorial Centre and ImmunoACT.
CAR-T therapy uses a patient’s own immune cells, which are modified to recognise and attack cancer cells. The development of an Indian-made therapy represents an important step towards expanding access to advanced cell-based cancer treatment.
AI and Genomics Transforming Diagnosis
Indian researchers are also exploring the use of artificial intelligence and genomic information in cancer diagnosis.
AI systems can analyse large volumes of pathology images, genetic information and patient data, potentially helping doctors identify cancer more accurately and develop treatment strategies tailored to individual patients.
Robotic Surgery Adds Precision
Advanced surgical technology is another area where cancer care is evolving.
Robotic surgery programmes in Indian hospitals are being used to improve precision during complex procedures, with the potential to reduce surgical trauma and shorten recovery times in suitable patients.
Molecular Profiling Supports Personalised Treatment
Cancer is not a single disease, and patients with the same type of cancer can respond differently to treatment.
Researchers are therefore combining molecular profiling with computational tools to understand the biological characteristics of individual tumours. Such approaches could help doctors select therapies more precisely.
The Push for Affordable Innovation
India’s large patient population and healthcare-cost challenges make affordability an important part of cancer innovation.
Developing therapies, diagnostic tools and research capabilities domestically could reduce dependence on expensive imported technologies and potentially make advanced treatment more accessible to a wider group of patients.
AI Could Accelerate Cancer Research
Artificial intelligence is also being explored as a research tool rather than simply a diagnostic aid.
AI models can analyse complex biological information and generate hypotheses that researchers can subsequently test experimentally. This could help scientists identify new mechanisms and potential therapeutic targets more quickly.
Cancer Genomics and Precision Medicine
Another important direction is precision medicine, which uses information about a tumour’s genetic and molecular characteristics to guide treatment.
For India, developing stronger cancer-genomics capabilities could be particularly valuable because the country’s diverse population may have disease patterns and genetic characteristics that are not fully represented in global datasets.
Innovation Must Reach Patients
Scientific breakthroughs alone do not guarantee better cancer outcomes.
New therapies and technologies still need rigorous clinical testing, regulatory approval, trained professionals, appropriate infrastructure and affordable access before they can benefit patients at scale.
A Growing Cancer Research Ecosystem
India’s cancer innovation landscape includes universities, government research institutions, hospitals, biotechnology companies and pharmaceutical organisations.
Their work spans cell therapy, genomics, AI, diagnostics, surgery and drug development, creating a broader ecosystem around cancer research and treatment.
The Road Ahead
Indian laboratories are increasingly moving beyond conventional research towards technologies that could change how cancer is detected and treated.
The challenge now is to translate promising laboratory discoveries into safe, clinically proven and affordable treatments that can reach patients across India.